Our mission is to bring pharmaceutical manufacturers and 340B covered entities together to improve 340B program transparency. In 2018 and 2019, over 30% of HRSA audits identified duplicate Medicaid rebates. In many instances, it is the complexity of the U.S. healthcare system that is the primary factor resulting in duplicate discounts. Fortunately, the solution is not complex. 340B covered entities and pharmaceutical manufacturers can work together to solve these issues and 340B ESP™ can make that happen.
Connecting 340B covered entities and
340B ESP™ is an innovative
A key hurdle in bringing pharmaceutical manufacturers and 340B covered entities together to address duplicate discounts is the sheer volume of data. 340B ESP™ technology overcomes this hurdle. Our proprietary platform allows 340B covered entities to securely upload 340B claims data through a simple to use interface and then links it to Medicaid and commercial rebate data maintained by pharmaceutical manufacturers.
Our team has worked with 340B covered entities, contract pharmacies, pharmaceutical manufacturers, wholesalers, PBMs, and software vendors on a wide range of 340B initiatives over the past 10 years. This broad industry experience informed the development of 340B ESP™ to ensure that all 340B program stakeholder perspectives are incorporated into our solution. We are excited to continue collaborating with 340B program stakeholders to address the biggest program integrity issues facing the 340B program today.
Over 10 years of experience working with 340B covered entities, contract pharmacies, pharmaceutical manufacturers, PBMs and wholesalers
Get in contact with us - We want to hear from you. Our team members will be in touch with you within 24 hours.